Portola Pharmaceuticals Inc., South San Francisco (United States of America)
Contributor content
Event: ESC Congress 2017
Topic: Primary cardiovascular prevention: interventions and outcomes
Session: Prevention general
Topic: Basic Science
Session: Cardiovascular care - Biology II